OBJECTIVES: Thoracic cage flatness, the so-called flat chest, is a chest wall deformity associated with end-stage lung disease requiring lung transplantation. There is little information on the impact of flat chest on lung transplantation. The purpose of this study was to investigate whether flat chest directly influences respiratory function and survival after cadaveric lung transplantation.
INTRODUCTION
Lung transplantation is the only effective therapy for patients with advanced, end-stage lung disease refractory to the medical treatment. An adequate size match between a donor and a recipient, as determined by predicted vital capacity calculated from gender, age and height, is of crucial importance for success. Size mismatch is associated with an increased duration of intensive care stay, frequency of tracheostomy, atelectasis, postoperative respiratory functions and exercise capacity [1] [2] [3] . However, little consideration has been given to the shape of the recipient thorax, which can be important in creating a good match.
Barrel chest is a well-known acquired deformity of the thoracic cage in patients with advanced pulmonary emphysema. It is possible that a long-standing increase in intrathoracic pressure, caused by overinflated lungs, associated with obstructive ventilatory impairment, leads to an expansion of the thoracic cage into the barrel chest condition. In contrast, the thoracic cage of patients with end-stage restrictive lung disease is occasionally flattened, and the ratio of the anteroposterior diameter to the transverse diameter of the thoracic cage is abnormally lower than in normal populations. Although the actual association between this so-called flat chest condition and respiratory disorder is unclear, some reports suggest that this chest wall deformity may be an acquired transformation of the thoracic cage associated with the process of fibrosis in the lungs of patients with pleuroparenchymal fibroelastosis [4] . The new classification of idiopathic interstitial pneumonias was established in 2013, and pleuroparenchymal fibroelastosis was recognized as a specific rare entity of idiopathic interstitial pneumonias [5] . As flat chest was recognized as a characteristic condition in these patients, the discussion has focused on whether lung transplantation for patients with pleuroparenchymal fibroelastosis can extend their prognosis or can improve their postoperative respiratory function in relation to chest flatness.
We previously reported a correlation between chest flatness and pulmonary functions in bilateral living-donor lobar lung transplantation (LDLLT) [6] . Although postoperative pulmonary function was significantly poorer for patients with flat chests than for those with normal chests, their postoperative exercise capacity was equivalent. Relatively small lobar grafts may actually be beneficial for patients with small chest cavities due to flat chests.
However, it is unclear whether a relatively large-sized graft functions properly in a narrowed chest cage in cadaveric lung transplantation. In this study, we attempted to make our previous findings on bilateral LDLLT more useful to the global population by investigating the impact of flat chest on respiratory function and survival in cadaveric lung transplantation.
MATERIALS AND METHODS
Eighty-nine cadaveric lung transplantations were performed in Kyoto University Hospital (Kyoto, Japan) between August 2010 and September 2017. Twenty-one recipients with chronic obstructive pulmonary disease (COPD) and lymphangioleiomyomatosis were excluded from the study because only 2 of these patients had flat chest; their inclusion would have biased the non-flat chest group significantly and affected preoperative respiratory function values and perioperative parameters. Preoperative chest computed tomography (CT) results and perioperative clinical data were reviewed. To analyse postoperative graft function relative to preoperative thoracic shape, patients were divided into 2 groups (flat and nonflat chest groups) based on the diagnostic criteria according to our previous report [6] . Flat chest is diagnosed when the ratio of the anteroposterior thoracic diameter to the transverse thoracic diameter on chest CT is 1/3 or less. A Synapse Vincent (Fuji Film Co., Ltd., Tokyo, Japan), a high-speed and high-quality 3D image analysis system, was used to obtain 3D images of the preoperative thoracic cage [7] . We used the distance from the posterior surface of the sternum to the anterior surface of the 8th thoracic vertebra in measuring the anteroposterior diameter, and from the right to left chest wall at the level of the diaphragm in measuring the transverse diameter. Individuals were included in the flat chest group when this ratio was 1/3 or less prior to lung transplantation and in the non-flat chest group when the ratio was more than 1/3 prior to lung transplantation. Postoperative respiratory function was evaluated by the ratio of postoperative measured lung function values, such as graft forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV 1 ), to preoperative estimated donor graft function values. For downsizing lobar transplantation patients, we used a formula for estimating graft FVC and FEV 1 based on the number of segments in the graft [8, 9] . The right upper lobe contains 3 segments, the right middle 2, the right lower 5, the left upper 5, the left lower 4 1 or FVC for at least 3 weeks without a clear alternative aetiology for the decrease in lung function [10] . The study was approved by the Institutional Review Board (R0393-2) of the Kyoto University Hospital. Written informed consent was waived because of the study's retrospective nature.
All statistical analyses were performed using StatMate IV for Windows (ATMS, Tokyo, Japan). Continuous data are presented as mean ± standard deviation. The relationships between flat chest and clinical parameters were evaluated using the Student's unpaired t-test and Fisher's exact test. Postoperative respiratory function was analysed for 23 patients with bilateral lung transplantation, which could provide an estimation of preoperative and postoperative lung function at 1 year after lung transplantation. Nine patients with bilateral lung transplantation were excluded from the analyses because of death, CLAD or a short follow-up period within 1 year after lung transplantation. Patients with single lung transplantation were also excluded from the analysis of postoperative respiratory function because the native lung affected postoperative pulmonary function. CLAD-free survival was calculated from the date of surgery until the time of CLAD diagnosis. The Kaplan-Meier method was used for survival curve analysis, and differences between survival curves were analysed using the log-rank test. Univariable and multivariable Cox proportional hazards models were used to estimate the impact of each clinical parameter on 5-year survival and CLAD-free survival. Independent variables identified as significantly associated with 5-year survival or CLAD-free survival in the univariable model and considered clinically important to influence survival were included into a multivariable model. The number of factors introduced into the multivariable model was calculated by considering the size and number of deaths or CLAD. A P-value <0.05 was considered statistically significant.
RESULTS
A total of 68 patients were included in this study. Thirty patients were assigned to the flat chest group and the remaining 38 to the non-flat chest group. Preoperative characteristics of the patients are presented in Table 1 . Median age and sex at the time of lung transplantation were comparable between the 2 groups. Body mass index and ratio of the thoracic anteroposterior diameter to the transverse diameter were significantly lower in the flat chest group (P < 0.001). The 2 groups did not differ in perioperative parameters, including duration of mechanical ventilation, delayed chest closure, postoperative tracheostomy, reoperation or primary graft dysfunction ( Table 2 ). In the event of significant size disparity between the lung graft and the chest cavity, downsizing of the graft through lobectomy was performed before lung implantation. The decision to tailor a lung was made empirically based on size disparity between the donor lung and a recipient pleural space, and the median value of size matching was 101.1% with whole lung transplantation and 114.4% with size-reduced lung transplantation (P = 0.006, data not shown). Tailoring of the lung was needed for 9 patients (30.3%) in the flat chest group and for 3 patients (7.8%) in the non-flat chest group (P = 0.04).
Bilateral graft lobectomy was performed in 6 patients with flat chest (Table 3) . One of the 3 cases of the non-flat chest group required right lower lobectomy because of graft injury.
When preoperatively measured respiratory function was compared between the 2 groups (Table 1) , both FVC and %FVC were significantly different (preoperative FVC 1.68 ± 0.58 vs 2.07 ± 0.89 l, P = 0.03; preoperative %FVC 45.8 ± 18.5% vs 60.2 ± 19.6%, P < 0.001). In contrast, there were no significant differences in preoperative FEV 1 (1.43 ± 0.56 vs 1.61 ± 0.84 l, P = 0.32) and preoperative FEV 1 % (82.9 ± 21.2% vs 74.6 ± 21.2, P = 0.13) between the 2 groups. At the 1-year postoperative respiratory function assessment, there were no significant differences in the ratios of donor graft FVC to the preoperatively estimated FVC or the donor graft FEV 1 to the preoperatively estimated FEV 1 between the 2 groups (P = 0.61 and P = 0.48, respectively, Table 4 ). Total distance travelled in the 6-min walk test before and after lung transplantation was similar between the 2 groups (P = 0.08 and P = 0.66, respectively, Table 4 ). When the flatness of the thoracic cage at 1 year after lung transplantation was compared with that before surgery, there was a significant increase in the ratio of the thoracic anteroposterior diameter to the transverse diameter in the flat chest group (P = 0.01, Fig. 1A and B). The 5-year survival after lung transplantation was not significantly different between the groups (flat chest group 64.3% vs non-flat chest group 66.5%, P = 0.87, Fig. 2A ). The 5-year incidence of CLAD-free survival was 62.6% among flat chest recipients vs 70.0% among nonflat chest recipients. There was no significant difference between the 2 groups (P = 0.79, Fig. 2B ). The results of univariable and multivariable analyses of overall survival and CLAD-free survival are provided in Supplementary Material, Tables S1 and S2. Flat chest was found not to be a risk factor for 5-year survival (hazard ratio 1.396, 95% confidence interval 0.763-2.555; P = 0.278) and CLAD-free survival (hazard ratio 1.338, 95% confidence interval 0.715-3.504; P = 0.362).
DISCUSSION
In this study, there were no statistically significant differences in survival, postoperative pulmonary function or exercise capacity between the patients with flat chest and those with non-flat chest in cadaveric lung transplantation. We also found no significant differences in early postoperative parameters between the flat chest and non-flat chest groups. Furthermore, we noted that the flatness of the thoracic cage was significantly reversed in flat chest patients at 1 year after cadaveric lung transplantation. Although tailoring of the lung was occasionally needed, cadaveric lung transplantation for patients with flat chest was safely performed with encouraging survival results. It was previously unknown whether postoperative respiratory functional recovery of patients with flat chest would be obtained following cadaveric lung transplantation. Theoretically, flat chest patients were thought to have a disadvantage with respect to pulmonary function over non-flat chest patients, because chest wall compliance of flat chest patients was less than that expected in non-flat chest patients. In this study, preoperative lung function values including FVC and %FVC in the flat chest group were significantly lower than those of the non-flat chest group. If the decrease in pulmonary function was caused by the chest cage, then a decrease in function after lung transplantation might be expected. However, the postoperative pulmonary function of patients with flat chest was not statistically different from those with non-flat chest at 1 year after lung transplantation. The improvement in pulmonary function would then lead to the best possible result in CLAD-free and 5-year survival. In terms of exercise capacity, there were no significant differences in the 6-min walk distance between the 2 groups 1 year after lung transplantation. These results have great clinical importance for pulmonologists who refer these patients to lung transplantation centres. We previously reported an association between flat chest and respiratory function in bilateral LDLLT [6] . Pulmonary functions were significantly lower in patients with flat chest than in those with non-flat chest after LDLLT. These data suggested that the whole lung, not the lobe, might contribute more to an improved postoperative lung function after cadaveric lung transplantation than after LDLLT. Unlike a cadaveric lung transplantation, respiratory function in LDLLT patients is entirely dependent on the bilateral lower lobes. Intrathoracic pressure related to the increase of chest cavity volume is lower in LDLLT compared to cadaveric lung transplantation because the lobe is not perfectly opposed to the chest wall, a situation that occurs with bilateral cadaveric grafts. The details of this improvement are complicated and undoubtedly multifactorial.
Severe congenital chest wall deformities including pectus excavatum are well-known causes of chronic respiratory failure [11] . Flat chest, which may result from a congenital disposition or may be an acquired deformity of the thoracic cage associated with the process of lung fibrosis, is frequently observed in restrictive lung disease. It has been unclear whether any improvement of this deformity could be obtained. In the current study, a flattening of the thoracic cage with a progressive respiratory disorder was improved by cadaveric lung transplantation, in addition to the results of LDLLT as previously reported by our group [6] . In contrast, a change in the ratio of the thoracic anteroposterior diameter to the transverse diameter in the non-flat chest group was limited. These results showed that a relatively large-sized graft increased chest cavity volume and decreased negative intrathoracic pressure with flat chest patients. Grafts with good compliance might improve thoracic wall mobility through reducing chest wall rigidity.
Size mismatch can lead to severe complications in the perioperative period and chronic problems after lung transplantation. Therefore, in Japan, donor grafts are allocated when the ratio of the donor's predicted vital capacity to the recipient's predicted vital capacity is 0.7 to 1.3. Some opinions suggest that significantly oversized allografts are associated with an increase in risks, such as perpetual atelectasis, distortion of the bronchial anatomy with retention of secretions and secondary infections. The risk of these complications would be higher in the flat chest group compared to the non-flat chest group because lung transplantation for patients with flat chest is conceptually similar to a mismatch of oversized transplanted lungs that are restricted to recipients with a smaller thorax. Size mismatch of the thoracic cage and graft would initiate ventilation disorders, lead to an increased effort in breathing and result in alveolar hypoventilation. Thus, after lung transplantation, longer periods of ventilation support using high airway pressure might be needed for flat chest patients compared to nonflat chest patients. Contrary to our expectation, there were no significant differences in postoperative tracheostomy or the intubation period between the 2 groups, and oversized grafts squeezed into narrow thoracic cages underwent effective adaptation. Technically, we had to perform 9 size-reduced lung transplantations for flat chest patients to avoid an increase in perioperative and postoperative complications. Lobar transplantation has previously been considered a risk of perioperative complication, such as delayed chest closure, tracheostomy, post-transplant extracorporeal membrane oxygenation for primary graft dysfunction, renal insufficiency and a longer intensive care unit (ICU) stay [12] [13] [14] . In this study, lobar transplantation was an independent risk factor of CLAD (see Supplementary Material, Table S2 ). Although lung volumetry, instead of predicted FVC or ratio of predicted total lung capacity of the donor to real total lung capacity of the recipient, might be useful for quantifying the degree of oversizing, CT images in cadaveric organ donors were not available. In addition, there was no standard value of lung volume for healthy people from which we could predict donor lung volume. Therefore, the decision to tailor the donor lung with flat chest patients should be made carefully based on size disparity between the donor lung and a narrow pleural space of the recipient.
Limitations
There were some limitations to this study that must be addressed. First, this was a single-institution retrospective study. To investigate the direct effect of flat chest on respiratory function, it was necessary to exclude 36 single-lung transplantations (17/30 in the flat chest group and 19/38 patients in the non-flat chest group) due to complications involving the native lung in postoperative respiratory function. In addition, 2 patients in the flat chest group and 7 patients in the non-flat chest group were excluded because of death, CLAD or a short follow-up period within 1 year after lung transplantation; thus, the number of patients included was small. The small sample size could have biased the analyses and therefore might not have led to an adequate assessment of the impact of flat chest on cadaveric lung transplantation. Second, we evaluated postoperative respiratory function using predicted donor respiratory function, which was determined by height, sex and age. Graft conditions might be poorer and less uniform in cadaveric lung transplantation compared to LDLLT, and it was difficult to measure actual donor graft function preoperatively. Lastly, our analysis of risk factors affecting postoperative respiratory function was limited to the thoracic cage; therefore, we cannot exclude the possibility of bias due to a variety of factors not accounted for, such as donor lung quality, allograft ischaemic time, infectious complications and comorbidities. Therefore, a multicentre, prospective clinical study involving a large sample size is needed to establish the suitability of flat chest patients for cadaveric lung transplantation.
CONCLUSION
In conclusion, the results of lung transplantation for flat chest patients were not statistically different from those for non-flat chest patients, including postoperative pulmonary function, exercise capacity and survival. Proper tailoring of the lung was occasionally necessary for flat chest recipients.
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